Navigation Links
Apelon Announces Availability of New TermManager® Software
Date:10/24/2011

RIDGEFIELD, Conn., Oct. 24, 2011 /PRNewswire/ -- Apelon, Inc., a leading provider of terminology and data interoperability solutions, today announced the availability of the first comprehensive, cloud-based terminology mapping solution. TermManager, a code set management and collaborative mapping application, cost-effectively supports healthcare data interoperability initiatives by enabling widespread access to national healthcare vocabulary standards including SNOMED CT®, LOINC®, ICD, RxNorm and NDF-RT. Using TermManager, individuals and organizations can map legacy information to required standards for Meaningful Use incentive payments, departmental data consolidation and regional integration. TermManager is today's answer to the mission-critical data interoperability needs of health systems.

Easy to use, TermManager is a virtual application that can be accessed by anyone with a web browser to manage sets of local terms and map them to national data standards. For instance, a lab manager can map local laboratory test names to LOINC concepts, or a medical records specialist can map their problem list to SNOMED CT. No infrastructure purchase is required, and flexible licensing terms are available facilitating widespread adoption and encouraging greater use of mapping for terminology normalization.

"Mapping local terms to national and international standards is a fundamental requirement for healthcare data to be comparable and interoperable," said Stephen Coady, Apelon's President and CEO.  "By innovating the distribution model for TermManager, Apelon is further supporting the needs of data standardization and interoperability in Electronic Medical Records systems and Healthcare Information Exchanges. TermManager will enable Accountable Care Organizations, hospitals, laboratories, EMR vendors and decision support companies alike, to standardize and manage their data sets, leading to more accurate and comparable reporting, identification of best proven practices and reduction of practice variation."

TermManager maintains local code sets and the latest versions of industry standard code systems, including Meaningful Use subsets, in a secure infrastructure with around-the-clock access by registered users. Accurate, up-to-date mappings are assured through the use of Apelon's proven TermWorks matching technology, and role-based access control is available with flexible workflow processes for review and approval.  An additional product differentiator is the unique capability for users to view map results made by other members of the TermManager community, further enhancing learning and increasing map development efficiency.

For further information about TermManager, visit www.Apelon.com/TermManager

About Apelon

Apelon is an international clinical informatics company focusing on data standardization and interoperability. Apelon software and professional services helps leading healthcare enterprises, life sciences organizations and government agencies improve the quality, comparability and accessibility of their information.  Visit www.Apelon.com for additional information.

TermManager is a registered trademark of Apelon, Inc.


'/>"/>
SOURCE Apelon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Summary Breast cancer, a malignant neoplasm, is ... cancer in women worldwide, accounting for 16% of all ... of women diagnosed with breast cancer has increased over ... has declined due to earlier diagnosis and better treatment ... the past four decades, especially with increasing usage of ...
(Date:2/4/2016)... MOUNTAIN VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... supply management solutions to healthcare systems, today announced results ... 2015.  --> --> ... was $130.3 million, up $5.1 million or 4.1% from ... or 7.2% from the fourth quarter of 2014. Revenue ...
(Date:2/4/2016)... , Feb. 4, 2016 In response to the ... FDA,s Deputy Commissioner for Medical Products and Tobacco, along with ... reassess the agency,s approach to opioid medications. The plan will ... providing patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at ... of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, and ... , For Valentine’s Day, not only are long-stem roses available, but also other flower ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... ... February 05, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... again host, Swirl, A Wine Tasting Event at the La Gorce Country Club ...
(Date:2/5/2016)... Dallas, Texas (PRWEB) , ... February 05, 2016 , ... ... to allow users to search for and donate to Give To Cure’s campaign ... is an app that lets users make and share payments through a smart device. ...
(Date:2/5/2016)... MA (PRWEB) , ... February 05, 2016 , ... ... in tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, ... option with unmatched results. , Developed by Cynosure, the PicoSure has been approved by ...
Breaking Medicine News(10 mins):